NO20054395L - Poloksamer emulisjonspreparater - Google Patents

Poloksamer emulisjonspreparater

Info

Publication number
NO20054395L
NO20054395L NO20054395A NO20054395A NO20054395L NO 20054395 L NO20054395 L NO 20054395L NO 20054395 A NO20054395 A NO 20054395A NO 20054395 A NO20054395 A NO 20054395A NO 20054395 L NO20054395 L NO 20054395L
Authority
NO
Norway
Prior art keywords
poloxamer
emulsion preparations
emulsion
preparations
composition
Prior art date
Application number
NO20054395A
Other languages
English (en)
Inventor
Steen Boye Jorsal
Original Assignee
Novasel Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasel Australia Pty Ltd filed Critical Novasel Australia Pty Ltd
Publication of NO20054395L publication Critical patent/NO20054395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det er beskrevet en emulsjonssammensetning som omfatter en vandig komponent, en ikke-ionisk blokksampolymer og en olje hvori sampolymeren omfatter minst 10% regnet på vekten av sammensetningen.
NO20054395A 2003-02-27 2005-09-22 Poloksamer emulisjonspreparater NO20054395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003900887A AU2003900887A0 (en) 2003-02-27 2003-02-27 Poloxamer emulsion preparations
PCT/AU2004/000218 WO2004076561A1 (en) 2003-02-27 2004-02-20 Poloxamer emulsion preparations

Publications (1)

Publication Number Publication Date
NO20054395L true NO20054395L (no) 2005-09-22

Family

ID=31499933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054395A NO20054395L (no) 2003-02-27 2005-09-22 Poloksamer emulisjonspreparater

Country Status (9)

Country Link
EP (1) EP1597318A4 (no)
JP (1) JP2006519272A (no)
CN (1) CN100591721C (no)
AU (3) AU2003900887A0 (no)
BR (1) BRPI0408056A (no)
CA (1) CA2516863C (no)
EA (1) EA017434B1 (no)
NO (1) NO20054395L (no)
WO (1) WO2004076561A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210107137A (ko) * 2008-04-21 2021-08-31 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
WO2010076730A1 (en) * 2009-01-02 2010-07-08 Donald, Jenny Method for the treatment of an hiv infection
BR112012024673B1 (pt) 2010-04-01 2021-06-29 Palette Life Sciences AB Composição farmacêutica anestésica termogelificante e uso da mesma para a preparação de um medicamento para o tratamento de dor
PT2689774T (pt) 2011-03-21 2019-04-05 Broda Tech Co Ltd Composições de hidrogel termo-reversíveis reversivamente
ITMI20131927A1 (it) * 2013-11-20 2015-05-21 Cosmo Technologies Ltd Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection. emulsioni o microemulsioni per uso nella resezione mucosale endoscopica e/o dissezione submucosale endoscopica
CN106414552B (zh) * 2014-03-25 2020-08-25 豪夫迈·罗氏有限公司 制备用于细胞培养基中的泊洛沙姆的方法
US10351750B2 (en) 2017-02-03 2019-07-16 Saudi Arabian Oil Company Drilling fluid compositions with enhanced rheology and methods of using same
KR101852718B1 (ko) * 2017-04-04 2018-05-18 주식회사 제네웰 외과수술 후 절개부위 통증 감소를 위한 키트
KR102544922B1 (ko) * 2017-12-21 2023-06-16 시그마-알드리치 컴퍼니., 엘엘씨 폴록사머 조성물 및 이의 제조 및 사용 방법
IT201900018752A1 (it) * 2019-10-14 2021-04-14 Alessandro Tosetti Composizione a base di olii essenziali ad uso odontoiatrico per il trattamento della periodontite e della mucosite perimplantare
RU2762506C1 (ru) * 2021-01-20 2021-12-21 Общество С Ограниченной Ответственностью «Диамед-Фарма» Средство для аппликации полости рта и носа и способ его применения в составе комплексной терапии инфекционно-воспалительных заболеваний носовой и ротовой полости
CN114455621B (zh) * 2022-01-11 2023-10-27 兰州交通大学 一种针状碳酸钙的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4312489A (en) * 1988-09-23 1990-04-18 Cetus Corporation Lipid microemulsions for culture media
JPH0791555B2 (ja) * 1989-12-22 1995-10-04 株式会社資生堂 洗浄剤組成物
AU696855B2 (en) * 1994-03-18 1998-09-17 Shire Laboratories, Inc. Emulsified drug delivery systems
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition
DE19723308A1 (de) * 1997-06-04 1998-12-10 Wolfgang A Prof Dr Wohlrab Neue Mikroemulsionen zur topischen Anwendung von Arzneimittelwirkstoffen
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
WO2000051550A1 (en) * 1999-03-01 2000-09-08 Basf Corporation Cold processed water-in-oil emulsions
DE60028384T2 (de) * 1999-06-21 2007-05-16 Kuhnil Pharmaceutical Co., Ltd. Propofol enthaltende anästhetische zusammensetzung zur intravenösen injektion
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs

Also Published As

Publication number Publication date
BRPI0408056A (pt) 2006-02-14
EA200501368A1 (ru) 2006-02-24
EP1597318A4 (en) 2006-06-14
CA2516863C (en) 2011-12-06
EP1597318A1 (en) 2005-11-23
WO2004076561A1 (en) 2004-09-10
CN1753949A (zh) 2006-03-29
AU2009202265B2 (en) 2012-02-16
CN100591721C (zh) 2010-02-24
CA2516863A1 (en) 2004-09-10
AU2004215921A1 (en) 2004-09-10
EA017434B1 (ru) 2012-12-28
AU2009202265A1 (en) 2009-07-02
AU2003900887A0 (en) 2003-03-13
JP2006519272A (ja) 2006-08-24

Similar Documents

Publication Publication Date Title
NO20054395L (no) Poloksamer emulisjonspreparater
CY1117164T1 (el) Φαρμακευτικες συνθεσεις περιλαμβανουσες κολλοειδες διοξειδιο πυριτιου
FR14C0064I2 (fr) Anticorps anti-il-6, compositions, methodes et utilisations associees
WO2003028451A3 (en) Microbiocidal formulation comprising essential oils or their derivatives
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
ATE415166T1 (de) Antivirale pharmazeutische zusammensetzungen
WO2003045878A3 (en) 2,w-diaminocarboxylic acid compounds
BR0317715A (pt) Composições e processos de uso de collajolie
ATE376587T1 (de) Granulat mit hoher schlagfestigkeit
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
BR9916132B1 (pt) composiÇÕes e utilizaÇço das mesmas.
WO2004014893A3 (en) Antimicrobial aza-bicyclic derivates, their compositions and uses
BR0211259A (pt) Polìmero sólido solúvel em água
NO20055830D0 (no) Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme
RS52315B (en) DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
EP1471387A3 (en) Photosensitive composition and compound used thereof
NO20061088L (no) Protonpumpe inhibitor formuleringer og fremgangsmater for fremstilling og anvendelse av slike formuleringer
BRPI0500536A (pt) Composição antimicrobiana
BRPI0411705A (pt) composição, uso da competição, e, uso de pelo menos um extrato de ervas do gênero equisetum e de pelo menos um agente formador de filme
DE60136637D1 (en) Topische polymere antimikrobielle emulsion
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
DE602004015794D1 (de) Metalloxid-formulierungen
ATE352570T1 (de) Kosmetisches mittel enthaltend ein polysaccharid und ein organopolysiloxan-polyoxyalkylen- copolymer als emulgatoren
ATE375949T1 (de) Andockpuffer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application